JP2002541153A5 - - Google Patents

Download PDF

Info

Publication number
JP2002541153A5
JP2002541153A5 JP2000609430A JP2000609430A JP2002541153A5 JP 2002541153 A5 JP2002541153 A5 JP 2002541153A5 JP 2000609430 A JP2000609430 A JP 2000609430A JP 2000609430 A JP2000609430 A JP 2000609430A JP 2002541153 A5 JP2002541153 A5 JP 2002541153A5
Authority
JP
Japan
Prior art keywords
alkyl
ethyl
compound
ethenyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000609430A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002541153A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/002851 external-priority patent/WO2000059920A2/en
Publication of JP2002541153A publication Critical patent/JP2002541153A/ja
Publication of JP2002541153A5 publication Critical patent/JP2002541153A5/ja
Pending legal-status Critical Current

Links

JP2000609430A 1999-04-06 2000-03-31 経口活性アンドロゲン Pending JP2002541153A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99201070.2 1999-04-06
EP99201070 1999-04-06
PCT/EP2000/002851 WO2000059920A2 (en) 1999-04-06 2000-03-31 Orally active 7.alpha.-alkyl androgens

Publications (2)

Publication Number Publication Date
JP2002541153A JP2002541153A (ja) 2002-12-03
JP2002541153A5 true JP2002541153A5 (enExample) 2007-05-10

Family

ID=8240066

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000609430A Pending JP2002541153A (ja) 1999-04-06 2000-03-31 経口活性アンドロゲン

Country Status (10)

Country Link
US (2) US6756366B1 (enExample)
EP (1) EP1212345B1 (enExample)
JP (1) JP2002541153A (enExample)
AT (1) ATE246703T1 (enExample)
AU (1) AU5209600A (enExample)
CO (1) CO5160345A1 (enExample)
DE (1) DE60004377T2 (enExample)
ES (1) ES2204613T3 (enExample)
PE (1) PE20010029A1 (enExample)
WO (1) WO2000059920A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212345B1 (en) * 1999-04-06 2003-08-06 Akzo Nobel N.V. Orally active 7-alpha-alkyl androgens
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
US20050090476A1 (en) * 2002-01-21 2005-04-28 Arnoldus Maria Van Buggenum Patrick Process for the preparation of 7alpha-methylsteroids
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
KR101602802B1 (ko) * 2008-04-09 2016-03-11 페린 파마슈티칼즈, 인코포레이티드 고열 홍조에 대한 스테로이드 치료
AU2011343615A1 (en) * 2010-12-15 2013-05-09 Harbor Biosciences, Inc. Methods and compounds for preparing 3alpha-oxygen substituted steroids

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755689A (fr) * 1969-09-03 1971-03-03 Upjohn Co Procede de fabrication de nouvelles 7 beta-alkyl-19- nortestosterones
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
US6037339A (en) * 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
AU671706B2 (en) * 1993-03-05 1996-09-05 Akzo N.V. Use of a Pregnane Derivative
IL113816A (en) * 1994-06-08 1998-12-06 Akzo Nobel Nv Pharmaceutical compositions containing desogestrel their preparation and use
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
CN1119998C (zh) * 1995-06-22 2003-09-03 阿克佐诺贝尔公司 去氧孕烯的压制干颗粒片
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
ZA968873B (en) * 1995-11-06 1997-05-28 Akzo Nobel Nv Isomerisation of equillin
US5998639A (en) * 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
CA2200423C (en) * 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
US6506390B2 (en) * 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity
AU726016B2 (en) * 1997-05-16 2000-10-26 Akzo Nobel N.V. 20-aralkyl-5alpha-pregnane derivatives
TR199902873T2 (xx) * 1997-06-04 2000-04-21 Akzo Nobel N.V. Miyozun mod�lasyonu i�in 17�-aliloksi(tiyo)alkil-androstan t�revleri.
DE69702985T2 (de) * 1997-09-23 2001-02-15 Akzo Nobel N.V., Arnheim/Arnhem Steroid enthaltende Dosierungsformen mit einer steroiddichten Umhüllung
US6080773A (en) * 1997-10-14 2000-06-27 Akzo Nobel, N.V. Benzylamine derivatives which are useful in treating psychiatric disorders
EP1030669A2 (en) * 1997-11-14 2000-08-30 Akzo Nobel N.V. Progestogen-antiprogestogen regimens
DE69806640T2 (de) * 1997-12-18 2003-03-13 Akzo Nobel N.V., Arnheim/Arnhem 17beta-aryl(arylmethyl)oxy(thio)alkyl-androstanderivative
NZ506465A (en) * 1998-02-26 2003-08-29 Akzo Nobel Nv Derivatives of azetidine and pyrrolidine
CN1172949C (zh) * 1998-06-19 2004-10-27 阿克佐诺贝尔公司 睾酮衍生物
AU759344B2 (en) * 1998-12-11 2003-04-10 Akzo Nobel N.V. 22S-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
US6498153B1 (en) * 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
JP2002539134A (ja) * 1999-03-09 2002-11-19 アクゾ・ノベル・エヌ・ベー 減数分裂の阻害のための２２ｒ−ヒドロキシコレスタ−８，１４−ジエン誘導体
EP1212345B1 (en) * 1999-04-06 2003-08-06 Akzo Nobel N.V. Orally active 7-alpha-alkyl androgens
TW548277B (en) * 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens
JP2003508541A (ja) * 1999-09-06 2003-03-04 アクゾ・ノベル・エヌ・ベー １１位に炭化水素置換基を有する非芳香族エストロゲンステロイド
IL149424A (en) * 1999-12-02 2007-05-15 Organon Nv Androgens are converted to methylene at positions 15,14
ES2293986T3 (es) * 2000-03-27 2008-04-01 N.V. Organon Compuestos no esteroides tetraciclicos para tratamientos relacionados con el estrogeno.
ATE309208T1 (de) * 2000-08-23 2005-11-15 Akzo Nobel Nv 10-aryl-11h-benzo(b)fluoren-derivate und analoga als östrogene mittel

Similar Documents

Publication Publication Date Title
CN104334158B (zh) 经阴道递送抗孕素的调配物和方法
EP1551415B1 (en) Oral pharmaceutical composition comprising 15-hydroxytestosterone and its analogues
JP2011518845A5 (enExample)
JP2005500347A5 (enExample)
JP2010507685A5 (enExample)
JP2008526807A5 (enExample)
JP2008540482A5 (enExample)
JP2009512658A5 (enExample)
JP2008512426A5 (enExample)
JP6796693B2 (ja) 抗プロゲスチンの膣内送達用の製剤と方法
RU2007112939A (ru) 15в-замещенные стероиды с избирательной эстрогенной активностью
JP2002541153A5 (enExample)
JP2002520281A5 (enExample)
JP2019123756A (ja) 抗黄体ホルモンの無毒送達のための組成物および方法
JP2002518514A (ja) テストステロン誘導体
JP2006507311A5 (enExample)
CA2389025A1 (fr) Composition hormonale a base d'un progestatif et d'un oestrogene et son utilisation
JP2008534533A5 (enExample)
CN1119150C (zh) 在分隔的室中含有两种活性成分的透皮系统、其制备方法及其作为药物的用途
HK1211852A1 (en) Methods and compositions for treating progesterone-dependent conditions
JP2002539135A5 (enExample)
JPH09508911A (ja) デソゲストレルを含有する経皮適用剤
JP2003522795A5 (enExample)
EP1462106A1 (en) Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
HK40040572A (en) Formulations and methods for vaginal delivery of antiprogestins